Tropheryma whipplei endocarditis in Spain Case reports of 17 prospective cases
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
García Álvarez, Lara; Sanz, María Mercedes; Marín, Mercedes; Fariñas Álvarez, María del Carmen






Fecha
2016Derechos
Atribución 3.0 España
Publicado en
Medicine (2016) 95:26(e4058)
Editorial
Lippincott Williams & Wilkins
Resumen/Abstract
Tropheryma whipplei endocarditis is an uncommon condition with very few series and<90 cases reported in the literature. The aim of the study was to analyze the epidemiological, clinical, and outcome characteristics of 17 cases of T. whipplei endocarditis recruited in our country from a multicentric cohort from 25 Spanish hospitals from the Spanish Collaboration on Endocarditis?Grupo de Apoyo al Manejo de la Endocarditis infecciosa en España. From a total of 3165 cases included in the cohort, 14.2% were diagnosed of blood culture negative endocarditis (BCNE) and 3.5% of these had T. whipplei endocarditis. This condition was more frequent in men. The average age was 60.3 years. Previous cardiac condition was present in 35.3% of the cases. The main clinical manifestation was cardiac failure (76.5%) while fever was only present in the 35.3%. Ecocardiography showed vegetations in 64.7% of patients. Surgery was performed in all but 1 cases and it allowed the diagnosis when molecular assays were performed. A broad range rRNA 16S polymerase chain reaction was used for first instance in all laboratories and different specific targets for T. whipplei were employed for confirmation. A concomitant Whipple disease was diagnosed in 11.9% of patients. All patients received specific antimicrobial treatment for at least 1 year, with no relapse and complete recovery. T. whipplei endocarditis is an uncommon condition with an atypical presentation that must be considered in the diagnosis of BCNE. The prognosis is very good when an appropriate surgical management and antimicrobial-specific treatment is given.
Colecciones a las que pertenece
- D22 Artículos [1093]
Items relacionados
Mostrando ítems relacionados por título, autor, creador y tema.
-
Use of tocilizumab in kidney transplant recipients with COVID-1
Pérez Sáez, María J; Blasco, Miquel; Redondo Pachón, Dolores; Ventura Aguiar, Pedro; Bada Bosch, Teresa; Pérez Florez, Isabel; Melilli, Edoardo; Sánchez Cámara, Luis A; López Oliva, María O; Canal, Cristina; Shabaka, Amir; Garra Moncau, Nuria; Martín Moreno, Paloma L; López, Verónica; Hernández Gallego, Román; Siverio, Orlando; Galeano, Cristina; Espí Reig, Jordi; Cabezas, Carlos J; [et al.] (Wiley Periodicals Inc., 2020) -
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
Álvaro Gracia, Jose María; Sanchez-Piedra, Carlos; Manero, Javier; Ruiz-Lucea, María Ester; López-Vives, Laura; Bohorquez, Cristina; Martinez-Barrio, Julia; Bonilla, Gema; Vela, Paloma; García-Villanueva, María Jesús; Navío-Marco, María Teresa; Pavía, Marina; Galindo, María; Erausquin, Celia; González-Gay Mantecón, Miguel Ángel; Rua-Figueroa, Inigo; Pego-Reigosa, Jose M.; Castrejon, Isabel; Sanchez-Costa, Jesús T.; [et al.] (BMJ Publishing Group, 2021)
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
Peralta Fernández, Francisco Galo; Lamelo Otero, María; Álvarez García, Patricia; Velasco Arribas, María; Delgado-Iribarren, Alberto; Horcajada Gallego, Juan Pablo; Montero, María Milagro; Roiz Mesones, María Pía; Fariñas Álvarez, María del Carmen; Alonso Gutiérrez, Juan; Martínez Martínez, Luis
; Gutiérrez Macías, Alfonso; Álava Menica, José Ángel; Rodríguez Guardado, Azucena; Fleites, Ana; Navarro López, Vicente; Sirvent Quílez, Elia; Capdevila Morell, José Antonio (BioMed Central, 2012-10-05)